https://www.selleckchem.com/products/cc-92480.html
E.9.28) months. Higher baseline NYHA class, recurrent heart failure hospitalizations, absence of treatment with beta-blockers, angiotensin converting enzyme inhibitors/angiotensin receptor blockers and aldosterone antagonists were predictors of death on univariate analysis whereas none of these parameters were significant on multivariate analysis. Median survival of our DCM cohort with LVEF≤19% on medical therapy was over 7 years. Median survival of our DCM cohort with LVEF≤19% on medical therapy was over 7 years. We report the gender-
Like
Comment
Share
